What are the key takeaways from “Longevity: Can We Add Another 30 Years? | The Decade Ahead” on Equity Mates?

What is this episode about?

The global shift toward an aging population is fueling a massive expansion in the biotech and pharmaceutical sectors. Beyond just extending lifespans, the industry is pivoting toward 'health span'—improving the quality of life through AI-driven drug discovery, peptide therapies, and personalized medicine, creating a multi-trillion-dollar investment opportunity.